NCT03794219

Brief Summary

Lateral epicondylitis (LE) is the most frequent painful musculoskeletal condition, which is characterized by a pain in the lateral epicondyle of the humerus and the common extensor tendon. The incidence of LE is approximately one to three percent of general population. LE is mostly the result of the overuse and repetitive movements of wrists and hands because of occupational or recreational activities. Diagnosis depends on clinical symptoms, history and physical examination including manual provocation tests. Magnetic resonance imaging, ultrasound (US), x-ray and electrophysiological assessment may be used in patient who do not response to conservative treatments. It is known that the radial nerve cross sectional-areas (CSAs) are increased in cases of refractory LE, although nerve conduction studies are normal. There is insufficient evidence to prove the superiority of any of conservative treatments to the others in patients with LE. The literature indicates that Kinesio taping decreases pain intensity, recovers grip strength, and improves functional status in patients with LE. The investigators design a randomized, single-blind, controlled trail to evaluate the effects of Kinesio taping both clinical and using ultrasonography.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 3, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 4, 2019

Completed
3 days until next milestone

Study Start

First participant enrolled

January 7, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 7, 2019

Completed
25 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2019

Completed
Last Updated

September 20, 2019

Status Verified

September 1, 2019

Enrollment Period

6 months

First QC Date

January 3, 2019

Last Update Submit

September 19, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline of pain on 2nd and 6th weeks

    Using the Visual analog scale (VAS) to measure the pain scale before treatment and multiple time frame after treatment. The VAS is a straight horizontal line of fixed length, 10cm. The ends are defined as the extreme limits of the parameter to be measured orientated from the left (worst, 0) to the right (best, 10).

    Pre-treatment, 2nd and 6th weeks after treatment

Secondary Outcomes (3)

  • Change from baseline of functional status on 2nd and 6th weeks

    Pre-treatment, 2nd and 6th weeks after treatment

  • Change from baseline of common extensor tendon (CET) thickness on 2nd and 6th weeks

    Pre-treatment, 2nd and 6th weeks after treatment.

  • Change from baseline of radial nerve cross-sectional area (CSA) on 2nd and 6th weeks

    Pre-treatment, 2nd and 6th weeks after treatment.

Study Arms (2)

Kinesio tape plus NSAID

EXPERIMENTAL

Kinesio tape is applied 3 times a week for 2 weeks with a total of 6 sessions in addition to 750 mg/day oral naproxen.

Other: Kinesio TapeDrug: oral naproxen

NSAID

ACTIVE COMPARATOR

750 mg/day oral naproxen is administered for 10 days.

Drug: oral naproxen

Interventions

To all patients,750 mg/day oral naproxen is administered for 10 days. Additionally, in intervention group kinesio tape is applied 3 times a week for 2 weeks with a total of 6 sessions.

Kinesio tape plus NSAID

750 mg/day oral naproxen is administered for 10 days.

Kinesio tape plus NSAIDNSAID

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • the presence of pain in the lateral elbow region at least for three months
  • tenderness around the lateral humeral epicondyle following at least one of these provocation tests: resisted wrist extension, resisted middle finger extension or passive stretch of wrist extensors.

You may not qualify if:

  • bilateral LE
  • presence of trigger point in the extensor muscles of the forearm
  • history of proximal upper extremity or neck symptoms
  • cervical pathology
  • central or peripheral neurologic disease
  • nerve entrapment syndromes
  • surgical treatments for LE
  • presence of condition that may prevent the patient using NSAIDs (i.e. gastrointestinal disorders, using anticoagulant)
  • trauma history of upper extremity
  • previous steroid injection around the lateral epicondyle
  • physical therapy targeted for LE in the past 6 months
  • presence of structures like fibrous bands, arc or recurrent radial artery around the radial nerve that may cause the entrapment of nerve
  • pregnancy and having any systemic disease that may cause swelling at nerves such as diabetes mellitus, renal insufficiency, thyroid disease or rheumatic disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Basak Mansiz-Kaplan

Ankara, 06230, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Tennis Elbow

Interventions

Athletic TapeNaproxen

Condition Hierarchy (Ancestors)

Elbow TendinopathyTendinopathyMuscular DiseasesMusculoskeletal DiseasesElbow InjuriesArm InjuriesWounds and InjuriesTendon Injuries

Intervention Hierarchy (Ancestors)

BandagesEquipment and SuppliesOrthotic DevicesOrthopedic EquipmentSurgical EquipmentNaphthaleneacetic AcidsNaphthalenesPolycyclic Aromatic HydrocarbonsHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsPolycyclic Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator of Department of Physical Medicine and Rehabilitation

Study Record Dates

First Submitted

January 3, 2019

First Posted

January 4, 2019

Study Start

January 7, 2019

Primary Completion

July 7, 2019

Study Completion

August 1, 2019

Last Updated

September 20, 2019

Record last verified: 2019-09

Locations